Skip to main content
. 2020 Sep 18;73(9):e2908–e2917. doi: 10.1093/cid/ciaa1418

Table 3.

Clinical and Resource Utilization Outcomes for a Model of Coronavirus Disease 2019 Infection and Testing in Massachusetts

Scenario PCR Tests per Simulation, d, Mean PCR Tests, Total Hospital Bed-days ICU Bed-days Cumulative Self-isolation Days
Cumulative Peak Cumulative Peak
Slowing scenario (1 June 2020, Re = 0.9)
 Hospitalized 2900 521  800 126  300 2200 76  600 1000
 Symptomatic 4800 861  500 91  200 2200 55  500 900 1  731  000
 Symptomatic + asymptomatic once 35 100 6  318  200 87  100 2200 51  600 900 1  948  900
 Symptomatic + asymptomatic monthly 192 200 34  593 900 77  300 2200 45  600 900 2  251  900
Intermediate scenario (1 June 2020, Re = 1.3)
 Hospitalized 2900 530  400 257  500 2200 149  100 1000
 Symptomatic 5900 1  053  100 133  100 2200 80  700 900 2  802  000
 Symptomatic + asymptomatic once 36  300 6  534  100 123  200 2200 70  800 900 2  897  300
 Symptomatic + asymptomatic monthly 193  500 34  823 700 93  400 2200 56  300 900 2  942  600
Surging scenario (1 June 2020, Re = 2.0)
 Hospitalized 3100 549  300 639  800 7100 377  300 4100
 Symptomatic 13  900 2  498  800 469  200 4600 264  600 2500 10  974 100
 Symptomatic + asymptomatic once 46  800 8  418  900 442  900 4300 250  600 2500 11  326 700
  Symptomatic + asymptomatic monthly 209  300 37  672 900 265  700 2300 144  600 1200 10  694 400

Includes events occurring during the 180-day horizon between simulated days 1 May 2020 and 1 November 2020. Strategies are listed by increasing number of tests utilized. PCR tests, hospital bed-days, ICU bed-days, and self-isolation days are rounded to the nearest 100. In-text results describing percentages are calculated from unrounded results. Cumulative self-isolation days are estimated in addition to the hospitalized strategy.

Abbreviations: ICU, intensive care unit; PCR, polymerase chain reaction; Re, effective reproduction number.